Anti-XDH/ XAN1/ XO functional antibody

Anti-XDH/ XAN1/ XO functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to XDH/XDH products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T40954-Ab-1/ GM-Tg-hg-T40954-Ab-2Anti-Human XDH monoclonal antibodyHuman
GM-Tg-rg-T40954-Ab-1/ GM-Tg-rg-T40954-Ab-2Anti-Rat XDH monoclonal antibodyRat
GM-Tg-mg-T40954-Ab-1/ GM-Tg-mg-T40954-Ab-2Anti-Mouse XDH monoclonal antibodyMouse
GM-Tg-cynog-T40954-Ab-1/ GM-Tg-cynog-T40954-Ab-2Anti-Cynomolgus/ Rhesus macaque XDH monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T40954-Ab-1/ GM-Tg-felg-T40954-Ab-2Anti-Feline XDH monoclonal antibodyFeline
GM-Tg-cang-T40954-Ab-1/ GM-Tg-cang-T40954-Ab-2Anti-Canine XDH monoclonal antibodyCanine
GM-Tg-bovg-T40954-Ab-1/ GM-Tg-bovg-T40954-Ab-2Anti-Bovine XDH monoclonal antibodyBovine
GM-Tg-equg-T40954-Ab-1/ GM-Tg-equg-T40954-Ab-2Anti-Equine XDH monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T40954-Ab-1/ GM-Tg-hg-T40954-Ab-2; GM-Tg-rg-T40954-Ab-1/ GM-Tg-rg-T40954-Ab-2;
GM-Tg-mg-T40954-Ab-1/ GM-Tg-mg-T40954-Ab-2; GM-Tg-cynog-T40954-Ab-1/ GM-Tg-cynog-T40954-Ab-2;
GM-Tg-felg-T40954-Ab-1/ GM-Tg-felg-T40954-Ab-2; GM-Tg-cang-T40954-Ab-1/ GM-Tg-cang-T40954-Ab-2;
GM-Tg-bovg-T40954-Ab-1/ GM-Tg-bovg-T40954-Ab-2; GM-Tg-equg-T40954-Ab-1/ GM-Tg-equg-T40954-Ab-2
Products NameAnti-XDH monoclonal antibody
Formatmab
Target NameXDH
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-XDH benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T40954-Ag-1Recombinant multi-species XDH/ XAN1/ XO protein
    ORF Viral VectorvGMAD000414human XDH Adenovirus particle
    ORF Viral VectorpGMAD000414human XDH Adenovirus plasmid
    ORF Viral VectorvGMAD000009human XDH Adenovirus particle
    ORF Viral VectorpGMAD000009human XDH Adenovirus plasmid


    Target information

    Target IDGM-T40954
    Target NameXDH
    Gene ID7498,22436,497811,708046,280960
    Gene Symbol and SynonymsXAN1,XDH,XO,XOR,Xox-1,Xox1
    Uniprot AccessionP47989,P22985,P80457
    Uniprot Entry NameXDH_HUMAN,XDH_RAT,XDH_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000158125
    Target ClassificationN/A

    The target: XDH, gene name: XDH, also named as XAN1, XO, XOR. Xanthine dehydrogenase belongs to the group of molybdenum-containing hydroxylases involved in the oxidative metabolism of purines. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. Xanthine dehydrogenase can be converted to xanthine oxidase by reversible sulfhydryl oxidation or by irreversible proteolytic modification. Defects in xanthine dehydrogenase cause xanthinuria, may contribute to adult respiratory stress syndrome, and may potentiate influenza infection through an oxygen metabolite-dependent mechanism. [provided by RefSeq, Jan 2014].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.